Frequently Asked Questions
The market is segmented based on , By Product Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Device Type (Self-monitoring and Diagnostic), Delivery Type (Pumps, Pen, Syringes, Injectors, Cartridges in Reusable pens, Disposable Pens, and Jet Injectors), Distribution Channel (Institutional Sales, Retail Sales) – Industry Trends and Forecast to 2030.
.
The Europe Diabetes Care Devices Market size was valued at USD 6.12 USD Billion in 2022.
The Europe Diabetes Care Devices Market is projected to grow at a CAGR of 5.88% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, PHC Holdings Corporation, WellDoc , Sanofi, Dexcom , DarioHealth Corp., Medtronic, B. Braun SE, F. Hoffmann-La Roche Ltd, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tidepool, Tandem Diabetes Care, LifeScan, AgaMatrix, Glooko , DarioHealth
-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
